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Abstract
Purpose The purpose of this study is to record the 30-day and
inpatient morbidity and mortality in paediatric patients in a
tertiary neuroscience centre over a 2-year period. The inten-
tions were to establish the frequency of significant adverse
events, review the current published rates of morbidity in pae-
diatric neurosurgical patients and propose three clinical indi-
cators for future comparison.
Methods All deaths and adverse events were prospectively
recorded from 1 January 2014 to 31 December 2015. Each
adverse event was categorised, allocated a clinical impact se-
verity score and linked to a neurosurgical procedure wherever
possible. Where a patient suffered several adverse events in
the same admission, each event was recorded separately. If a
patient had been discharged home, an adverse event was re-
corded if it occurred within 30 days of admission.
Results Five hundred forty-nine procedures were performed
in 287 patients (aged <16 years). One hundred thirty signifi-
cant adverse events were identified. The following are the
three clinical indicators: significant adverse event rate: 111
(20.2%) operations were linked to at least one significant ad-
verse event; unscheduled return to theatre rate: 81 (14.8%)
operations were associated with an adverse event that resulted
in an unscheduled return to theatre; and surgical site infection
rate: 29 (5.3%) operations were associated with an infection.
Conclusion Complications and adverse events are common in
paediatric neurosurgery. Prospective, continuous surveillance
will promote both quality assurance and quality improvement
in the neurosurgical care delivered to patients.
Keywords Adverse event . Complication . Paediatric .
Neurosurgery . Surveillance
Introduction
The French vascular surgeon Rene Leriche [7] famously
wrote:
BEvery surgeon carries about him a little cemetery, in
which from time to time he goes to pray, a cemetery of
bitterness and regret, of which they seek the reason for
certain of their failures^.
In recent years, there has been much greater scrutiny of ad-
verse events in healthcare systems and a surgeon’s personal cem-
etery is no longer private but to be opened for public scrutiny.
Individual consultant surgeon- and institution-specific
mortality rates have been published in the UK since 2014.
When first published, the NHS Medical Director, Sir Bruce
Keogh, said that surgeons had a moral responsibility to make
public their death rates, in arguing that this was a means to
defend how well they delivered a service; he directly linked
surgical outcome data to quality and safety.
Morbidity and mortality should be recorded in a systematic
way; in addition to recording any adverse event, the system
must also define the denominator—how often could such an
event have occurred, to determine the true rate. When com-
parisons can be made between units, the standard of care can
be defined.
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We sought to devise a system for the prospective surveil-
lance of all morbidity and mortality in paediatric patients
(<16 years) admitted to our hospital. Our system was based
on the model devised by Drake and colleagues [5] but was
adapted and extended to include a qualitative assessment of
impact on the patient’s experience. We present our results
following 2 years of data collection, propose three quality
indicators that would permit ongoing monitoring of quality
and comparison between units and review the current litera-
ture on morbidity in paediatric neurosurgical patients.
Methods
The paediatric neurosurgical unit at the Royal Hospital for
Children, Glasgow, is the largest unit in Scotland, and in ad-
dition to providing neurosurgical care to the population of the
west of Scotland (population 2.7 million), it is one of the
designated supra-regional national UK centres for craniofacial
surgery. The unit has four consultant paediatric neurosur-
geons, a specialist trainee, a fellow, an advanced nurse practi-
tioner and a clinical nurse specialist.
The model devised is based on that proposed by Drake and
colleagues [5], each adverse event categorised in the scheme
outlined in Table 1.
To be included, an adverse event had to occur either during
their inpatient stay or if discharged within 30 days of surgery.
Wherever possible, the adverse event is linked to the appro-
priate neurosurgical operation.
Each potential adverse event is prospectively recorded and
then discussed at a monthly review meeting (chaired by the
unit clinical governance lead, EC). The adverse event is
assigned a category and linked to the appropriate operation.
An additional patient impact score was assigned using our
organisation’s matrix for severity categorisation of complica-
tions [11] (Table 2).
If the adverse event resulted in the patient returning to
theatre for a further procedure, the impact score was a mini-
mum of 3. An adverse event with an impact score 3, 4 or 5 was
termed significant.
A governance meeting, attended by the entire paediatric
neurosurgical unit, with representation from allied medical
and surgical specialties is held every quarter. At this meeting,
each event is reviewed and the final decisionwhether it is to be
included in the morbidity database, its category and impact
score is agreed. All inpatient deaths are also reviewed.
Multiple complications in the same patient were counted sep-
arately, and each was linked to the appropriate procedure, if
the patient had undergone more than one procedure.
Three key indicators were identified to permit monitoring
of quality of care delivered:
1. Significant adverse event rate—the proportion of opera-
tions to which at least one significant adverse event was
linked to.
2. Unscheduled return to theatre rate—the proportion of op-
erations which subsequently required an unplanned return
to theatre due to a recorded significant adverse event.
3. Surgical site infection rate—the proportion of operations
that were linked to any adverse event affecting the surgi-
cal site (wound, shunt or drain infections).
The database was recorded and analysed on Microsoft
Excel, and chi-squared test was used to analyse categorical
variables and a two-sample t test to analyse continuous vari-
ables. The project was approved by the local clinical gover-
nance support unit.
Results
Data was prospectively collected from 1 January 2014 until
the 31 December 2015 for all patient aged <16 years, admitted
under the care of the paediatric neurosurgical team. Five hun-
dred forty-nine procedures were performed in 287 patients
(163 males, 124 females). The mean age at the time of the
operation was 5.8 ± 5.0 years (mean ± standard deviation).
One hundred thirty-five (24.6%) operations were performed
in patients less than 1 year of age at the time of the operation.
One hundred thirty-eight (25.1%) operations were classi-
fied as routine; the remainder was non-elective (urgent and
emergency procedures). The principal surgeon was the
Table 1 Classification of complications
Surgical Neurological deficit New deficit
Meningitis Excluding indwelling drain
Seizures
Wound infection
CSF leak
EVD/lumbar drain infection Suspected or confirmed
Shunt blockage
Shunt infection Suspected or confirmed
Post-operative haemorrhage Managed medically
Post-operative haemorrhage Returned to theatre
Post-operative infarction
Other
Medical Cardiac
Respiratory Inc pneumonia
GI/hepatic
Renal/GU/UTI
Haematological/thromboembolic
Metabolic
Cognitive
Other
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consultant paediatric neurosurgeon in 307 procedures
(55.8%); the majority of the remainder of cases were per-
formed by a trainee as the principal surgeon, supervised by
the consultant paediatric neurosurgeon (228 procedures,
41.5%). A small minority of cases were performed by an adult
consultant neurosurgeon (14 procedures).
Eight patients died during the study period, six of whom
had undergone a neurosurgical procedure in our department
during their last hospital stay. All deaths were formally
reviewed at the quarterly governance meeting. In the review
of two of the deaths, it was concluded that given the underly-
ing diagnosis, the death was unexpected and the adverse
events that had occurred during the final inpatient stay were
likely to have contributed to the patient’s death. One patient
(31 days old) suffered an intraventricular haemorrhage follow-
ing embolisation of a vein of Galen malformation, an external
ventricular drain was inserted, but the baby never recovered
from the haemorrhage, and treatment was withdrawn. The
second death occurred in a 2-year 3-month-old child who
presented in coma with a posterior fossa tumour. Despite
emergency surgery and excision of the tumour, she suffered
a devastating hypoxic ischaemic brain injury and treatment
was ultimately withdrawn; histopathology showed the tumour
to be a pilocytic astrocytoma.
For the remaining six deaths, it was concluded that the
death was expected and the result of the underlying disease
process rather than any adverse event that had occurred.
The calculated crude mortality rate for patients undergoing
neurosurgery in our department was 6/287 = 2.1%.
One hundred ninety adverse events were recorded; 130 had
an impact score of 3 or greater and were termed significant.
Table 3 outlines the category and impact score of the recorded
Table 2 NHS Greater Glasgow and Clyde impact/severity descriptors
1 Negligible Reduced quality of patient experience/clinical outcome not directly related to delivery of clinical care
2 Minor Unsatisfactory patient experience/clinical outcome related to care provision—readily resolvable
3 Moderate Unsatisfactory patient experience/clinical outcome; short term effects—expect recovery <1 week
4 Major Unsatisfactory patient experience/clinical outcome; long-term effects—expect recovery >1 week
5 Extreme Unsatisfactory patient experience/clinical outcome; continued ongoing long-term effects
Table 3 Frequency of adverse
event by category and impact
score
Impact score, no. of events Total
1 2 3 4 5
Surgical Neurological deficit 3 3 12 1 19
Seizures 5 1 2 8
Wound infection 2 6 1 9
Wound breakdown 1 1 2 4
CSF leak 20 21 41
EVD/lumbar drain infection 2 6 1 9
Shunt blockage 27 3 30
Shunt infection 7 4 1 12
Post-operative haemorrhage (medical) 1 1 2
Post-operative haemorrhage (surgical) 1 1 2
Othera 4 7 8 3 1 23
Medical Cardiac 0
Respiratory 3 3 6
GI/Hepatic 1 1
Renal/GU/UTI 1 1
Haematological/thromboembolic 1 1
Metabolic 1 11 2 3 17
Other 2 2 1 5
Total 5 55 89 36 5 190
a The 12 surgical, significant adverse events (impact score 3, 4 or 5) recorded under ‘other’ included a delay in
treatment of raised ICP (1), injury to the small bowel during insertion of a ventriculoperitoneal shunt (1), pressure
sore (2), EVD blocked (3), dislocated right elbow (1), ICP monitor or vascular long line dislodged (2) and failure
to drain all ventricles following revision of VP shunt (2)
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adverse events. Thirty-one adverse events were medical, and
158 adverse events were surgical. The commonest adverse
event was a CSF leak; the commonest significant adverse
event was a shunt blockage.
Significant adverse event rate
One hundred eleven operations were linked to at least one
significant adverse event, giving a significant adverse event
rate of 20.2% (6/190 adverse events were not be linked to a
neurosurgical procedure).
Unscheduled return to theatre rate
Of the 549 operations performed, 81 were associated with an
adverse event that resulted in an unscheduled return to theatre,
14.8%.
Surgical site infection rate
Thirty operations were associated with a surgical site infection
or a suspected infection for which treatment was instigated; the
overall surgical site infection rate was 5.5% (30/549). The caus-
ative organism was identified in 23 of the 29 infections; 26 of
the infections were classified as a significant adverse event.
CSF diversion operations had a higher significant adverse
event rate (26.5%) compared to spinal operations and all other
cranial procedures (21.9 and 12.2%, respectively) (p < 0.001).
Within the subcategories of cranial surgery, tumour surgery
had the highest significant adverse event rate, 32.1%
(Table 4).
Routine operations had a lower significant adverse event
rate than non-routine operations (11.6 vs 23.1%, p = 0.004).
There was no real difference in the significant adverse
event rate in operations where the paediatric consultant was
the principal surgeon and where they were not (20.5 vs 19.8%,
p = 0.84). There was no statistical difference in the proportion
of male and female patients who experienced a significant
adverse event following surgery (male 21.4 vs 18.6%,
p = 0.42); nor was there any difference in the mean age of
patients who experienced a significant adverse event (6.23 vs
5.71 years, p = 0.33).
Discussion
In his recent book, ‘Black Box Thinking’ [17], Syed explores
how success happens and analyses the approach that different
industries and professions take when failure occurs. He draws
many parallels between the aviation industry and healthcare;
both are safety-critical, high-performance professions, which
utilise increasingly complex systems, but he argues that there
is a profound difference in how they approach adverse or
unexpected events. Pilots and aviation system experts per-
ceive such events as the consequence of the conflict between
the complexity of the system and their capacity to understand
it. In healthcare, Syed contends that too often, such events are
seen not as the inevitable consequence of complexity but as an
indictment of those who make them. Our development of a
surgical morbidity surveillance system is the first step in this
process of changing the culture to adverse events in our
department.
What is a surgical complication?
Dindo and Clavien [3] emphasised the distinction between the
failure to achieve the surgical goal and a complication in their
definition; Bany deviation from the ideal post-operative course
that is not inherent in the procedure and does not comprise a
failure to cure.^
Sokol and Wilson [16] differed and argued that an unde-
sired outcome, which would include a failure to cure, is per-
ceived as a surgical complication; Bany undesirable, unintend-
ed and direct result of an operation affecting the patient, which
would not have occurred had the operation gone as well as
could have been reasonably be hoped^.
Table 4 Category of operation
Category of operation Number of
operations
Number of operations
linked to significant
adverse event
Significant adverse
event rate (%)
Brain tumour 53 17 32.1
Epilepsy 8 0 0
Trauma 16 0 0
Craniofacial 48 3 6.3
Vascular 22 3 13.6
Other 83 5 5.6
All cranial 230 28 12.2
CSF diversion 287 76 26.5
Spine 32 7 21.9
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If the goal of a prospective morbidity surveillance pro-
gramme is to identify areas where surgical care could be im-
proved, we argue that this should include when the primary
goal of the operation has not been achieved. We sought to
identify any adverse event that had occurred in patients admit-
ted under our care and thus adopted the Sokol and Wilson
definition that this would mean any clinical event that was
undesired and unintended.
Classification of surgical complications
The Clavien and Dindo classification [4] is the most
widely cited classification system; designed for general
surgery, its application has been extended to related sur-
gical specialties, for example to urology, and Ibanez
et al. [6] proposed a modified form of the system for
neurosurgical patients. The Clavien-Dindo system clas-
sifies a complication according to the therapy used to
treat it and thus is an assessment of impact severity;
for example, wound infection requiring surgical washout
and replacement of an external ventricular drain would
both be grade IIb: complication requiring intervention
with general anaesthesia. As it does not make a distinc-
tion between different categories of complication, its
practical use as a means for improving clinical practice
is more limited.
It is also important to remember that these systems were
designed for adult patients; taking action after an adverse
event in a child may require a greater level of intervention
than in an adult; for example, resuturing a wound or
performing a lumbar puncture may require a general anaes-
thetic in a child, but this is less likely in an adult; thus, the
grade of the complication will have increased.
We adopted the system proposed by Drake and colleagues
[5] for several reasons. Firstly, it was specifically designed for
neurosurgical patients and the categorisation of the complica-
tion by surgical and medical subgroups would be easily ap-
plied in a busy paediatric neurosurgical unit. The same com-
plication occurring with different procedures could more eas-
ily be identified. Secondly, the system has been adopted by
other paediatric neurosurgical units [19], permitting a compar-
ison between units. Lastly by linking each complication to an
operation, the Drake system creates a simple and easily count-
ed denominator. This gives a more accurate assessment of the
significant adverse event rate than linking it to individual pa-
tients; for example, estimating the 30-day shunt blockage rate
is more meaningful if we compare the number of shunts that
blocked in 30 days to the total number of shunts inserted,
rather than the total number of patients who underwent the
procedure.
We modified the model to include an assessment of patient
impact severity, using our organisation’s clinical risk matrix.
Drake et al. [5] classified morbidity Bas any significant
adverse outcome or death^; we felt that the term significantly
needed to be more precisely defined. Whilst our system is
simpler than the Clavien-Dindo system, we believe that the
dual categorisation of an event adds strength.
Comparison of complication rates
Our significant adverse event rate was 20.2%; in comparison
to other units using the same system, Drake et al. [5] reported
an overall complication rate of 16.4% over 2 years and van
Lindert et al. [19] reported an overall complication rate of
20.2%. Using a different system, Patel et al. [13] also
reviewed all cranial and spinal surgery and published a 30-
day morbidity rate of 15.0%. Taking into account differences
in interpretation and data collection, we believe that our result
that approximately one in five neurosurgical procedures re-
sulted in an adverse event is in keeping with current published
rates for paediatric neurosurgical units.
Moiyadi et al. [9] and Neervoort et al. [10] reviewed the
morbidity associated with cranial operations for CNS tumours
and identified morbidity rates of 44.4 and 68.6%, respectively.
We found that our cranial operations for tumour have a signif-
icant adverse event rate of 32.1%; this trend of higher morbid-
ity for tumour operations in comparison to the overall morbid-
ity rate within a unit was also recorded by van Lindert [19],
32.7%, and Drake [5], 27.9%. This study supports the view
that morbidity following tumour surgery is greater than other
types of neurosurgery in paediatric patients.
In reviewing our significant adverse event rates, we identi-
fied that our significant adverse event rate (SAER) was greater
for CSF diversion procedures, 26.5% (shunt insertion and
revision, external ventricular drain insertion, endoscopic pro-
cedures and open craniotomy procedures for arachnoid cysts),
than for other cranial procedures or spinal procedures. This
appeared to be higher than that published by other units (van
Lindert et al. [19] 21.8% and Drake et al. [5] 15.4%). In light
of this finding, a detailed analysis of the CSF diversion pro-
cedures was completed. It was found that the SAER was
highest for shunt procedures (71 new shunt insertions and 75
shunt revisions) and the commonest surgical complication
was shunt blockage. Whilst it appeared that during the 2-
year period of the study, we had at least three complex patients
in whom it proved extremely difficult to maintain a working
CSF drainage system, our department identified several areas
where intraoperative technique could be modified with the
aim of reducing the frequency of early shunt failure.
We reported an unscheduled (30 days) return to theatre rate
of 14.8%; this excluded those patients who had a planned
return to theatre for a planned second operation, for example
tumour resection after a first operation to treat hydrocephalus.
A rate of 14.8% is in keeping with the rates published by
other paediatric neurosurgical units; Van Lindert and col-
leagues [19] reported their unscheduled return to theatre rate
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of 10.5%; Mukerji and colleagues [9] reported a 30-day un-
planned reoperation rate of 17%.
Mukerji et al. advocated the adoption of an unplanned re-
operation rate as a quality indicator; we agree with their view
that it is an easily counted, common event that is non-discre-
tionary. They reviewed all reoperations in a 2-year period and
found that the majority of the reoperations (61%) occurred
within 30 days of the original operation (median time between
first and unplanned reoperations was 9 days).
The necessity in identifying the causative organism in a
surgical site infection has been extensively debated. We ar-
gued that if there was a clinical suspicion of an infection, for
example, a child with symptoms of meningitis, a fever and a
raised white cell count in their CSF following a shunt revision,
the failure to identify the causative organism did not delay or
defer treatment; therefore, any child who underwent treatment
of an infection should be defined as having an infection.
We linked 29 operations to a surgical site infection: 5.3% of
all procedures. Interestingly, the causative organism was iden-
tified in 22 of these infections, which if we had used the criteria
of identification of the causative organism, employed by other
units, would have given a surgical site infection rate of 4.0%.
These rates of surgical site infection are in keeping with
that published by other units for both all types of neurosurgery
and specific subtypes (Table 5).
Conclusion
Whilst most paediatric neurosurgery centres review their mor-
bidity and mortality, we believe that our unit’s surveillance
model has formalised this process and permits an ongoing
method of both quality assurance and quality improvement
in the care that we provide for our patients.
The model that we have adopted was specifically designed
for paediatric neurosurgery, and our experience has been that
it can be implemented into a busy unit with minimal disrup-
tion of day-to-day clinical activity.
The proposed three key indicators will provide a means for
comparison between units for both overall and subcategories
of surgery, thus further promoting quality assurance within
our speciality.
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